Siga Technologies (SIGA) Stock Price, News & Analysis

Company Overview

Siga Technologies, Inc. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of novel medical countermeasures to address orthopoxvirus infections such as smallpox and mpox. Headquartered in Maryland, the company combines proprietary antiviral research with government-sponsored programs to deliver therapeutics designed for rapid response to biological threats. Since its formation in 2012, Siga has positioned itself as a key supplier of approved antiviral therapies while continuing to expand its pipeline of next-generation treatments.

The company’s flagship product is TPOXX (tecovirimat), the first FDA-approved antiviral for smallpox. TPOXX is manufactured under stringent cGMP conditions and is held in the U.S. Strategic National Stockpile through contracts with the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense. In addition to smallpox, Siga is advancing research into related orthopoxviruses and exploring broad-spectrum antiviral candidates to address emerging viral threats.

Siga serves a global customer base that includes U.S. federal agencies, international health organizations and allied government partners. The company has established supply agreements with the European Commission and is engaged with public health authorities in Canada, Australia and select NATO members. Siga’s operations encompass research laboratories in New York, strategic manufacturing partnerships in North America and Europe, and a regulatory team dedicated to securing approvals in key jurisdictions.

Under the leadership of Chairman and Chief Executive Officer Philip Gomez, Siga’s senior management team brings extensive experience in pharmaceutical development, government contracting and commercial operations. Chief Financial Officer John Dahl oversees corporate strategy and finance, while the board of directors features former public health officials and biodefense experts. Together, they guide Siga’s mission to strengthen global preparedness through innovative antiviral solutions.

Key Stats

• Today's Range: $6.88 to $7.07
• 50-Day Range: $5.25 to $6.90
• 52-Week Range: $4.95 to $12.83
• Volume: 367,807 shs
• Average Volume: 718,849 shs
• Market Capitalization: $492.94 million
• P/E Ratio: 10.30
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Siga Technologies Stock Analysis - MarketRank™

Siga Technologies scored higher than 30% of companies evaluated by MarketBeat, and ranked 859th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Siga Technologies.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 20.19%

Earnings Growth

Earnings for Siga Technologies are expected to grow by 20.19% in the coming year, from $1.04 to $1.25 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Siga Technologies is 10.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.14.

Price to Earnings Ratio vs. Sector

The P/E ratio of Siga Technologies is 10.30, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 19.58.

Price to Book Value per Share Ratio

Siga Technologies has a P/B Ratio of 2.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.56% of the float of Siga Technologies has been sold short.

Short Interest Ratio / Days to Cover

Siga Technologies has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Siga Technologies has recently increased by 0.33%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Siga Technologies does not currently pay a dividend.

Dividend Growth

Siga Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.56% of the float of Siga Technologies has been sold short.

Short Interest Ratio / Days to Cover

Siga Technologies has a short interest ratio ("days to cover") of 6.2.

Change versus previous month

Short interest in Siga Technologies has recently increased by 0.33%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.40

News Sentiment

Siga Technologies has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Siga Technologies this week, compared to 3 articles on an average week.

Search Interest

Only 3 people have searched for SIGA on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Siga Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.95% of the stock of Siga Technologies is held by insiders.

Percentage Held by Institutions

55.40% of the stock of Siga Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SIGA Stock Analysis - Frequently Asked Questions

How have SIGA shares performed this year?

Siga Technologies' stock was trading at $6.01 at the start of the year. Since then, SIGA stock has increased by 14.8% and is now trading at $6.90.

How were Siga Technologies' earnings last quarter?

Siga Technologies Inc. (NASDAQ:SIGA) posted its quarterly earnings data on Thursday, May, 8th. The company reported ($0.01) earnings per share for the quarter. The company earned $7.04 million during the quarter. Siga Technologies had a trailing twelve-month return on equity of 25.21% and a net margin of 40.30%.
Read the conference call transcript.

Who are Siga Technologies' major shareholders?

Top institutional investors of Siga Technologies include Harbor Capital Advisors Inc. (0.19%) and Wealth Enhancement Advisory Services LLC (0.08%).
View institutional ownership trends.

How do I buy shares of Siga Technologies?

Shares of SIGA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Siga Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Siga Technologies investors own include Voyager Therapeutics (VYGR), American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Record date for 5/15 Dividend: 4/29/2025
• Ex-Dividend for 5/15 Dividend: 4/29/2025
• Last Earnings: 5/08/2025
• Dividend Payable: 5/15/2025
• Today: 7/10/2025
• Next Earnings (Estimated): 7/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SIGA
• CIK: 1010086
• Web: www.siga.com
• Phone: (212) 672-9100
• Fax: 212-697-3130
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.67
• Trailing P/E Ratio: 10.51
• Forward P/E Ratio: 6.77
• P/E Growth: N/A
• Net Income: $59.21 million
• Net Margins: 40.30%
• Pretax Margin: 51.79%
• Return on Equity: 25.21%
• Return on Assets: 22.05%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.40
• Quick Ratio: 6.28

Sales & Book Value

• Annual Sales: $138.72 million
• Price / Sales: 3.63
• Cash Flow: $0.87 per share
• Price / Cash Flow: 8.09
• Book Value: $3.02 per share
• Price / Book: 2.33

Miscellaneous

• Outstanding Shares: 71,440,000
• Free Float: 70,048,000
• Market Cap: $502.87 million
• Optionable: Optionable
• Beta: 0.94